Newsroom-Katalog
Zeit | Debiopharm International SA: Meldungen vom 17.05.2023 |
---|---|
09:05 | DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS |
Zeit | Debiopharm International SA: Meldungen vom 17.05.2023 |
---|---|
09:05 | DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS |